Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-09-30 Sale |
2024-09-30 8:38 pm |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
40,000 | $14.06 | $562,324 | 81,000 (Direct) |
View |
2022-11-18 Purchase |
2022-11-22 08:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
10,000 | $1.8945 | $18,945 | 75,374 (Direct) |
View |
2022-09-08 Purchase |
2022-09-12 09:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
10,308 | $2.8 | $28,862 | 65,374 (Direct) |
View |
2022-09-06 Purchase |
2022-09-08 09:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
9,692 | $2.5558 | $24,771 | 55,066 (Direct) |
View |
2022-06-06 Purchase |
2022-06-07 08:00 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
19,727 | $2.63 | $51,882 | 45,374 (Direct) |
View |
2021-11-18 Purchase |
2021-11-19 09:16 am |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
11,187 | $5.82 | $65,108 | 25,647 (Direct) |
View |
2021-09-14 Purchase |
2021-09-16 6:22 pm |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
12,000 | $7 | $84,000 | 14,460 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-25 Option Award |
2024-11-26 4:12 pm |
N/A 2029-11-25 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
42,553 | $1.175 | 245,412 (Direct) |
View |
2024-10-09 Option Award |
2024-10-10 4:05 pm |
N/A 2034-10-09 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
75,000 | $0 | 75,000 (Direct) |
View |
2024-09-30 Exercise |
2024-09-30 8:38 pm |
N/A 2024-10-08 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
40,000 | $0 | 81,000 (Direct) |
View |
2024-09-30 Exercise |
2024-09-30 8:38 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
40,000 | $10.48 | 81,000 (Direct) |
View |
2024-08-08 Option Award |
2024-08-08 5:30 pm |
N/A 2029-08-08 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
84,932 | $1.825 | 245,238 (Direct) |
View |
2024-05-08 Option Award |
2024-05-10 4:05 pm |
2025-05-08 2034-05-07 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
26,000 | $0 | 100,500 (Direct) |
View |
2024-01-22 Option Award |
2024-01-23 4:15 pm |
N/A 2034-01-22 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
100,000 | $0 | 100,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-19 4:05 pm |
2024-05-17 2033-05-16 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
18,000 | $0 | 88,000 (Direct) |
View |
2023-01-18 Option Award |
2023-01-20 4:05 pm |
N/A 2033-01-18 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
100,000 | $0 | 100,000 (Direct) |
View |
2022-05-11 Option Award |
2022-05-12 8:26 pm |
2023-05-11 2032-05-10 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
12,000 | $0 | 79,000 (Direct) |
View |
2022-01-26 Option Award |
2022-01-28 4:30 pm |
N/A 2032-01-26 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
200,000 | $0 | 200,000 (Direct) |
View |
2021-08-04 Option Award |
2021-08-06 5:00 pm |
N/A 2031-08-04 |
Indaptus Therapeutics Inc. | INDP | Meckler Jeffrey A CEO and Director |
375,000 | $0 | 375,000 (Direct) |
View |
Ownership |
2021-08-02 4:45 pm |
N/A N/A |
Intec Parent Inc. | NTEC | Meckler Jeffrey A Chief Executive Officer |
0 | $0 | 16,086 (Direct) |
View |
2021-05-14 Option Award |
2021-05-18 9:19 pm |
2022-05-14 2031-05-13 |
Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director |
12,000 | $0 | 76,000 (Direct) |
View |
2020-07-15 Option Award |
2020-07-17 4:38 pm |
N/A 2027-07-15 |
Intec Pharma Ltd. | NTEC | Meckler Jeffrey A Chief Executive Officer |
300,000 | $0 | 300,000 (Direct) |
View |
2020-05-15 Option Award |
2020-05-19 8:00 pm |
2021-05-15 2030-05-14 |
Retrophin Inc. | RTRX | Meckler Jeffrey A Director |
12,000 | $0 | 73,000 (Direct) |
View |